Clinical Chemistry Impact Factor Rises to 12.167, the Highest in the History of the Journal

2022-06-30
WASHINGTON, June 30, 2022 /PRNewswire/ -- AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that the impact factor of its journal Clinical Chemistry has risen to 12.167 in the 2021 Clarivate Journal Citation Reports. This impact factor places Clinical Chemistry in the top 2% of 21,430 ranked academic journals and reaffirms that it is the top journal on medical laboratory technology—a position it has held for more than a decade.
Laboratory medicine professionals have played a vital role in managing the coronavirus pandemic by developing and performing tests for the virus, and by ensuring patient access to these tests. As the most trusted and authoritative journal in laboratory medicine, Clinical Chemistry has supported this work by disseminating essential research on all aspects of coronavirus testing. Clinical laboratory testing is also key to diagnosing and managing a broad range of other conditions—from diabetes to cancer—and the journal has continued to publish peer-reviewed papers that drive testing forward for all of these diseases.
Clinical Chemistry's high impact factor is a testament to the innovative and rigorous nature of this research, as is the journal's 2021 immediacy index of 2.7, which places it in the top 3% of all academic journals. A journal's impact factor is based on the number of times articles published in the journal are cited over a two-year period, while the immediacy index is determined by the journal citations in a single calendar year. Both are calculated by Clarivate, a recognized authority for evaluating the usefulness of a journal.
"We are thrilled to see this jump in Clinical Chemistry's impact factor," said AACC President Dr. Stephen R. Master. "The journal's editorial board and AACC staff have worked tirelessly to maintain—and exceed—Clinical Chemistry's high standards. It is very gratifying to see that this hard work has paid off, and that Clinical Chemistry has succeeded in providing valuable scientific information on laboratory medicine at a time when COVID-19 has challenged the field more than ever."
About AACC
Dedicated to achieving better health through laboratory medicine, AACC brings together more than 70,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.aacc.org.
Clinical Chemistry (clinchem.org) is the leading international journal of laboratory medicine, featuring nearly 400 peer-reviewed studies every year that help patients get accurate diagnoses and essential care. This vital research is advancing areas of healthcare ranging from genetic testing and drug monitoring to pediatrics and appropriate test utilization.
Christine DeLong
AACC
Senior Manager, Communications & PR
(p) 202.835.8722
[email protected]
Molly Polen
AACC
Senior Director, Communications & PR
(p) 202.420.7612
(c) 703.598.0472
[email protected]
SOURCE AACC
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。